Pulmonary Arterial Hypertension (PAH) Quality Enhancement Research Initiative Extension Program

Approval Date: 10/13/2011

Principal Investigator: Samuel Allen, DO

To improve the management of PAH patients through evidence-based approach aimed at achieving optimal WHO functional class.  This study is seeking patients with a specific condition, pulmonary arterial hypertension.

Eligibility:

Contact Person:
Coleen Tessmar, RN, Research Manager
248-964-8524

Status of Clinical Trial:
open and enrolling